Loading...
Loading...
CSII| Name | Value |
|---|---|
| Revenues | 59.7M |
| Cost of Revenue | 16.7M |
| Gross Profit | 43.0M |
| Operating Expense | 53.9M |
| Operating I/L | -10.9M |
| Other Income/Expense | 0.3M |
| Interest Income | 0.7M |
| Pretax | -10.7M |
| Income Tax Expense | -0.0M |
| Net Income/Loss | -10.6M |
Cardiovascular Systems, Inc. is a medical technology company specializing in developing and commercializing solutions for treating peripheral and coronary artery diseases globally. The company's primary revenue comes from its peripheral artery disease products, including catheter-based platforms for treating various plaque types in the lower limbs, addressing limitations of surgical and pharmacological treatments. Additionally, it offers the Diamondback 360 Coronary orbital atherectomy system for facilitating stent delivery in patients with severely calcified coronary artery lesions. The company also provides support products, guidewires, catheters, balloons, and other related products for these treatments.
